SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shalby soars as its arm gets nod to invest in Shalby Global Technologies

18 Dec 2023 Evaluate

Shalby is currently trading at Rs. 321.45, up by 6.35 points or 2.02% from its previous closing of Rs. 315.10 on the BSE.

The scrip opened at Rs. 315.05 and has touched a high and low of Rs. 329.50 and Rs. 312.00 respectively. So far 65895 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 329.50 on 18-Dec-2023 and a 52 week low of Rs. 114.35 on 28-Mar-2023.

Last one week high and low of the scrip stood at Rs. 329.50 and Rs. 307.70 respectively. The current market cap of the company is Rs. 3474.13 crore.

The promoters holding in the company stood at 74.12%, while Institutions and Non-Institutions held 4.11% and 21.77% respectively.

Shalby’s wholly?owned Subsidiary -- Mars Medical Devices (MMDL) has received approval to invest 2,00,000 Preference Shares of SGD 1 each in Shalby Global Technologies, Singapore (SGTPL). SGTPL is a subsidiary of Mars Medical Devices and a Step?down Subsidiary of the Company. With the aforesaid investment, preference shareholding of MMDL in SGTPL will be 100% and there will not be any change in equity shareholding and remained at 99.33%. The Board of Directors of company’s Wholly?owned Subsidiary has at its meeting held on December 18, 2023 approved the same. 

Shalby is a chain of Multi-specialty tertiary care hospitals based out of Ahmedabad. It has combined bed strength of more than 700 beds with its multispecialty hospitals across Gujarat and Goa.


Shalby Share Price

160.80 1.20 (0.75%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×